Biomea Fusion BMEA
NASDAQ BMEA
$1.76 +0.05 (+2.92%)
As of: Sep 22, 2026 · 11:19 AM EDT

Biomea Fusion (BMEA) Sales of Property, Plant and Equipment (2026)

Analysis

Biomea Fusion (BMEA) Sales of Property, Plant and Equipment (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn 63.00 Mn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn -
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn -
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn 26.00 Mn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn -
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn -
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn 363.82 Mn
8 Revolution Medicines 40.91 Bn 40.91 Bn - -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn 5.85 Mn
10 Biomea Fusion 132.65 Mn 132.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 550,000.00
API Access

Biomea Fusion Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=BMEA&period=max&api_key=YOUR_API_KEY